tiprankstipranks
Advertisement
Advertisement

SE:CINPHA Stock Latest News

Cinclus Pharma Clears Key Phase III Milestone in Erosive GERD Trial
Company AnnouncementsCinclus Pharma Clears Key Phase III Milestone in Erosive GERD Trial
10d ago
Cinclus Pharma Details 2026 Interim Progress and Market Focus
PremiumCompany Announcements
Cinclus Pharma Details 2026 Interim Progress and Market Focus
24d ago
Cinclus Pharma sets August 19 date for Q2 2026 results presentation
PremiumCompany Announcements
Cinclus Pharma sets August 19 date for Q2 2026 results presentation
1M ago
Cinclus Pharma Hits Phase III Enrollment Milestone in Severe GERD Trial
PremiumCompany Announcements
Cinclus Pharma Hits Phase III Enrollment Milestone in Severe GERD Trial
2M ago
Cinclus Pharma Advances Linaprazan Glurate Heart‑Safety Study, Keeping GERD Pipeline on Track
PremiumCompany Announcements
Cinclus Pharma Advances Linaprazan Glurate Heart‑Safety Study, Keeping GERD Pipeline on Track
3M ago
Cinclus Pharma Hits Phase III Milestone in Erosive GERD Trial
PremiumCompany AnnouncementsCinclus Pharma Hits Phase III Milestone in Erosive GERD Trial
3M ago
Cinclus Pharma Withdraws Key Phase 3 GERD Trial, Resetting Expectations for Linaprazan Glurate
Premium
Company Announcements
Cinclus Pharma Withdraws Key Phase 3 GERD Trial, Resetting Expectations for Linaprazan Glurate
4M ago
Cinclus Pharma AGM backs new share mandate and long-term incentive plan
Premium
Company Announcements
Cinclus Pharma AGM backs new share mandate and long-term incentive plan
4M ago
Cinclus Pharma Publishes Q1 2026 Interim Report Highlighting Late-Stage Pipeline and Market Potential
PremiumCompany Announcements
Cinclus Pharma Publishes Q1 2026 Interim Report Highlighting Late-Stage Pipeline and Market Potential
4M ago
Cinclus Pharma Sets May 13 Webcast for First-Quarter 2026 Report
PremiumCompany Announcements
Cinclus Pharma Sets May 13 Webcast for First-Quarter 2026 Report
5M ago
Cinclus Pharma Calls 2026 AGM, Sets Rules for Shareholder Participation
PremiumCompany Announcements
Cinclus Pharma Calls 2026 AGM, Sets Rules for Shareholder Participation
5M ago
Cinclus Pharma Ramps Up Investor Outreach Ahead of Late-Stage GERD Drug Push
PremiumCompany Announcements
Cinclus Pharma Ramps Up Investor Outreach Ahead of Late-Stage GERD Drug Push
5M ago
Cinclus Pharma Secures Up to EUR 28 Million to Accelerate Late-Stage Acid-Reflux Drug
PremiumCompany AnnouncementsCinclus Pharma Secures Up to EUR 28 Million to Accelerate Late-Stage Acid-Reflux Drug
6M ago
Cinclus Pharma Gains Boost as FDA Backs Single Pivotal Study Path for GERD Drug
Premium
Company Announcements
Cinclus Pharma Gains Boost as FDA Backs Single Pivotal Study Path for GERD Drug
7M ago
Cinclus Pharma Boosts 2025 Revenue but Maintains Heavy R&D-Driven Losses
Premium
Company Announcements
Cinclus Pharma Boosts 2025 Revenue but Maintains Heavy R&D-Driven Losses
7M ago
Cinclus Pharma Wins FDA Backing for Linaprazan Glurate Nonclinical Plan
PremiumCompany Announcements
Cinclus Pharma Wins FDA Backing for Linaprazan Glurate Nonclinical Plan
7M ago
Cinclus Pharma Gains EMA Backing on Manufacturing Plan for GERD Drug
PremiumCompany Announcements
Cinclus Pharma Gains EMA Backing on Manufacturing Plan for GERD Drug
7M ago
Cinclus Pharma Sets Date for Fourth-Quarter 2025 Report and Investor Presentation
PremiumCompany Announcements
Cinclus Pharma Sets Date for Fourth-Quarter 2025 Report and Investor Presentation
7M ago
Cinclus Pharma Confirms Seven-Member Board and Appoints New Director at Extraordinary Meeting
PremiumCompany Announcements
Cinclus Pharma Confirms Seven-Member Board and Appoints New Director at Extraordinary Meeting
8M ago
Cinclus Pharma Advances Phase 3 GERD Maintenance Trial: Why Linaprazan Glurate Matters for Investors
PremiumCompany AnnouncementsCinclus Pharma Advances Phase 3 GERD Maintenance Trial: Why Linaprazan Glurate Matters for Investors
8M ago
Cinclus Pharma’s Linaprazan Glurate Gains China Reimbursement Listing
Premium
Company Announcements
Cinclus Pharma’s Linaprazan Glurate Gains China Reimbursement Listing
9M ago
Cinclus Pharma Appoints New CFO Amidst Strategic Advancements
Premium
Company Announcements
Cinclus Pharma Appoints New CFO Amidst Strategic Advancements
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >